Australia Stock Exchange release from FIREBRICK PHARMA : FRE to file appeal seeking immediate approval of Nasodine
28/02/2022 22:44
Australia Stock Exchange release from FIREBRICK PHARMA FRE.AX : FRE to file appeal seeking immediate approval of Nasodine
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement